Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$374,016,511
+$32,443,683 QoQ
Shares Held
2,386,527
+6.7% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#11
of 1,606 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $3,560,811,525 across 15 Drug Manufacturers - General names. NVS ranks #5 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
876,181 | $1,050,917,864 | |
| 2 | JNJ |
Johnson & Johnson
|
1,962,221 | $498,345,267 | |
| 3 | ABBV |
AbbVie Inc.
|
1,561,703 | $392,986,942 | |
| 4 | AZN |
Astrazeneca PLC
|
1,978,508 | $375,164,686 | |
| 5 | NVS |
Novartis AG
This page
|
2,386,527 | $374,016,511 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,857,628 | $367,205,197 | |
| 7 | AMGN |
Amgen Inc
|
381,869 | $138,282,402 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
954,962 | $120,649,899 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $374,016,511 | 2,386,527 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $341,572,828 | 2,236,156 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $115,587,725 | 838,382 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $115,418,306 | 900,018 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $104,189,367 | 860,998 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $97,207,215 | 871,970 | Shares | Other | 2025-05-08 | |
| 2024-12-31 | $84,899,568 | 872,465 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $107,985,835 | 938,844 | Shares | Other | 2024-11-06 | |
| 2024-06-30 | $97,147,623 | 912,527 | Shares | Other | 2024-08-01 | |
| 2024-03-31 | $89,635,337 | 926,655 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $94,015,892 | 931,127 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $94,511,513 | 927,857 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $93,887,672 | 930,410 | Shares | Other | 2023-08-15 | |
| 2023-03-31 | $82,629,984 | 898,152 | Shares | Other | 2023-05-11 | |
| 2022-12-31 | $113,545,423 | 1,251,603 | Shares | Other | 2023-01-27 | |
| 2022-09-30 | $105,026,512 | 1,381,746 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $120,335,216 | 1,423,580 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $152,748,705 | 1,740,726 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $147,885,790 | 1,690,703 | Shares | Other | 2022-02-08 | |
| 2021-09-30 | $172,125,799 | 2,104,742 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $125,079,364 | 1,370,883 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $119,976,136 | 1,403,558 | Shares | Other | 2021-05-05 | |
| 2020-12-31 | $122,942,004 | 1,301,938 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $94,460,472 | 1,086,252 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $101,554,932 | 1,162,754 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $100,119,693 | 1,214,308 | Shares | Other | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||